Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How do we approach the goal of identifying everybody with Lynch syndrome?

Literature DB >> 23568035

How do we approach the goal of identifying everybody with Lynch syndrome?

Heather Hampel¹, Albert de la Chapelle.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23568035 PMCID： PMC4337020 DOI： 10.1007/s10689-013-9611-5

Source DB: PubMed Journal: Fam Cancer ISSN： 1389-9600 Impact factor: 2.375

× No keyword cloud information.

22 in total

1. Population-based molecular detection of hereditary nonpolyposis colorectal cancer.

Authors: R Salovaara; A Loukola; P Kristo; H Kääriäinen; H Ahtola; M Eskelinen; N Härkönen; R Julkunen; E Kangas; S Ojala; J Tulikoura; E Valkamo; H Järvinen; J P Mecklin; L A Aaltonen; A de la Chapelle
Journal: J Clin Oncol Date: 2000-06 Impact factor: 44.544

2. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.

Authors: L A Aaltonen; R Salovaara; P Kristo; F Canzian; A Hemminki; P Peltomäki; R B Chadwick; H Kääriäinen; M Eskelinen; H Järvinen; J P Mecklin; A de la Chapelle
Journal: N Engl J Med Date: 1998-05-21 Impact factor: 91.245

Review 3. The incidence of Lynch syndrome.

Authors: Albert de la Chapelle
Journal: Fam Cancer Date: 2005 Impact factor: 2.375

4. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

Authors: H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin
Journal: Gastroenterology Date: 2000-05 Impact factor: 22.682

5. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Authors: Kathleen M Schmeler; Henry T Lynch; Lee-may Chen; Mark F Munsell; Pamela T Soliman; Mary Beth Clark; Molly S Daniels; Kristin G White; Stephanie G Boyd-Rogers; Peggy G Conrad; Kathleen Y Yang; Mary M Rubin; Charlotte C Sun; Brian M Slomovitz; David M Gershenson; Karen H Lu
Journal: N Engl J Med Date: 2006-01-19 Impact factor: 91.245

6. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

Authors: Noralane M Lindor; Kari Rabe; Gloria M Petersen; Robert Haile; Graham Casey; John Baron; Steve Gallinger; Bharati Bapat; Melyssa Aronson; John Hopper; Jeremy Jass; Loic LeMarchand; John Grove; John Potter; Polly Newcomb; Jonathan P Terdiman; Peggy Conrad; Gabriella Moslein; Richard Goldberg; Argyrios Ziogas; Hoda Anton-Culver; Mariza de Andrade; Kim Siegmund; Stephen N Thibodeau; Lisa A Boardman; Daniela Seminara
Journal: JAMA Date: 2005-04-27 Impact factor: 56.272

7. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

Authors: Virgínia Piñol; Antoni Castells; Montserrat Andreu; Sergi Castellví-Bel; Cristina Alenda; Xavier Llor; Rosa M Xicola; Francisco Rodríguez-Moranta; Artemio Payá; Rodrigo Jover; Xavier Bessa
Journal: JAMA Date: 2005-04-27 Impact factor: 56.272

8. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Authors: Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Hidewaki Nakagawa; Kaisa Sotamaa; Thomas W Prior; Judith Westman; Jenny Panescu; Dan Fix; Janet Lockman; Ilene Comeras; Albert de la Chapelle
Journal: N Engl J Med Date: 2005-05-05 Impact factor: 91.245

9. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

Authors: J M Cunningham; E R Christensen; D J Tester; C Y Kim; P C Roche; L J Burgart; S N Thibodeau
Journal: Cancer Res Date: 1998-08-01 Impact factor: 12.701

10. Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.

Authors: M Porteous; M Dunckley; S Appleton; S Catt; M Dunlop; H Campbell; A Cull
Journal: Br J Cancer Date: 2003-10-20 Impact factor: 7.640

24 in total

Review 1. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.

Authors: Megan P Hitchins
Journal: Fam Cancer Date: 2016-07 Impact factor: 2.375

Review 2. Clinical management of hereditary colorectal cancer syndromes.

Authors: Hans F A Vasen; Ian Tomlinson; Antoni Castells
Journal: Nat Rev Gastroenterol Hepatol Date: 2015-01-13 Impact factor: 46.802

3. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.

Authors: Heather Hampel; Rachel Pearlman; Mallory Beightol; Weiqiang Zhao; Daniel Jones; Wendy L Frankel; Paul J Goodfellow; Ahmet Yilmaz; Kristin Miller; Jason Bacher; Angela Jacobson; Electra Paskett; Peter G Shields; Richard M Goldberg; Albert de la Chapelle; Brian H Shirts; Colin C Pritchard
Journal: JAMA Oncol Date: 2018-06-01 Impact factor: 31.777

4. Genetic counseling and cascade genetic testing in Lynch syndrome.

Authors: Heather Hampel
Journal: Fam Cancer Date: 2016-07 Impact factor: 2.375

Review 5. Brain Cancers in Genetic Syndromes.

Authors: Edina Komlodi-Pasztor; Jaishri O Blakeley
Journal: Curr Neurol Neurosci Rep Date: 2021-11-22 Impact factor: 5.081

6. Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer.

Authors: Malene Djursby; Thomas van Overeem Hansen; Karin A W Wadt; Majbritt Busk Madsen; Lukas Adrian Berchtold; Charlotte Kvist Lautrup; Sara Markholt; Uffe Birk Jensen; Lotte Nylandsted Krogh; Malene Lundsgaard; Anne Marie Gerdes; Mef Nilbert; Christina Therkildsen
Journal: Hum Genet Date: 2022-07-29 Impact factor: 5.881

7. MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.

Authors: Caroline Kientz; Fabienne Prieur; Alix Clemenson; Marie-Odile Joly; Marie-Laure Stachowicz; Jessie Auclair; Valéry Attignon; Renaud Schiappa; Qing Wang
Journal: Fam Cancer Date: 2019-11-19 Impact factor: 2.375